CELLULAR IMMUNOLOGY is a prestigious journal published by Academic Press Inc. Elsevier Science, dedicated to advancing the field of immunology. Established in 1970 and converging ongoing research up to 2024, this journal has carved out a significant niche within the academic community, boasting a notable Q2 ranking in the Immunology category and holding a respectable 67th percentile ranking within Scopus for its contributions to the disciplines of Immunology and Microbiology. The journal serves as a vital platform for disseminating high-quality research, reviews, and methodologies that elucidate the intricacies of cellular immune responses, thereby benefiting researchers, professionals, and students alike. Although it does not offer open access, the journal's impact is evidenced by its comprehensive coverage of pioneering studies and ongoing developments in the immunological sciences, positioning it as an essential resource for those seeking to deepen their understanding and engage with the latest findings in cellular immunology.

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.

Immune Network is a prestigious journal dedicated to disseminating high-quality research in the field of immunology, infectious diseases, and allergy, under the esteemed KOREA ASSOCIATION OF IMMUNOLOGISTS. Founded in 2016, this journal has quickly ascended to a top-tier publication, achieving Q1 rankings in 2023 in multiple relevant categories, including Immunology, Allergy, and Infectious Diseases. With a strong emphasis on innovation and interdisciplinary research, Immune Network appeals to a diverse audience of researchers, professionals, and students keen on advancing the understanding of immune responses and disease mechanisms. However, it is crucial to note that the journal operates under a subscription model without open-access provisions. Its impact factor further solidifies its reputation, reflecting the significant influence of the articles published. Located in South Korea, the journal serves as a global platform for sharing revolutionary insights and fostering collaborations within the immunology community.

TRENDS IN IMMUNOLOGY, published by CELL PRESS, stands as a premier source of insights and developments within the field of immunology. With an ISSN of 1471-4906 and E-ISSN of 1471-4981, this journal has established a strong reputation, evidenced by its prestigious status in Q1 quartiles for both Immunology and Allergy in 2023. It is ranked #13 out of 233 in the Scopus category of Medicine – Immunology and Allergy, and #16 out of 236 in Immunology and Microbiology, placing it within the top 94th and 93rd percentiles respectively. Since its inception in 1987, TRENDS IN IMMUNOLOGY has provided a critical platform for researchers, professionals, and students to access the latest advancements and integrative reviews in immunological research. The journal offers open access options, enhancing the accessibility of its high-impact content to a global audience. Researchers and practitioners rely on its pages not only for cutting-edge findings but also for comprehensive discussions that drive the future of immunology research.

The Journal of Innate Immunity, published by KARGER, stands at the forefront of immunological research, focusing on the critical role of innate immunity in health and disease. With its Open Access model since 2019, the journal ensures broad dissemination of groundbreaking findings and facilitates global scholarly communication. Based in Switzerland and indexed with an impressive Q1 category ranking in Immunology and Allergy for 2023, it occupies a prominent position in the scientific community, ranked #47 out of 233 in the field. Researchers, professionals, and students alike benefit from accessing high-quality, peer-reviewed articles that span from 2008 and will continue to evolve until 2024, reflecting the latest advances and challenges in innate immunity. As an essential resource, it addresses critical questions and shares innovative insights that push the boundaries of our understanding in this dynamic field.

Immunity, Inflammation and Disease is a premier open-access journal published by WILEY, dedicated to advancing the field of immunology and allergy. Launched in 2013, this journal has established itself as a significant platform for researchers and professionals to disseminate high-quality research findings and innovative insights that address critical issues in immune responses and inflammatory diseases. With an impact factor that reflects its growing influence and a current ranking in Q3 for Immunology and Q2 for Immunology and Allergy, this journal serves a diverse audience keen on exploring cutting-edge developments. Researchers are encouraged to submit their work to share their findings with a global reach, foster collaboration, and enhance the understanding of immune mechanisms and therapeutic strategies. Accessible since its inception, Immunity, Inflammation and Disease is committed to open science, ensuring that vital research is freely available for the advancement of knowledge within the academic community and beyond.

EXERCISE IMMUNOLOGY REVIEW, published by W W F VERLAGSGESELLSCHAFT GMBH, stands as a premier journal within the realms of Immunology, Medicine, and Sports Science. With an impressive Q1 ranking in these fields as of 2023, it is recognized for its significant contributions to understanding the interplay between physical activity and immune function. The journal, which has been publishing since 1996 and continues to evolve through 2024, serves as an essential resource for researchers, professionals, and students eager to explore cutting-edge findings and discussions. Although it is not an open access publication, its content is accessible through institutional subscriptions and individual purchases, ensuring its reach across a global audience. As the journal consistently ranks in the 96th percentile in General Medicine on Scopus, it underscores its vital role in advancing the dialogue on how exercise influences health and disease management.

The Bosnian Journal of Basic Medical Sciences, an esteemed publication within the field of medicine, serves as a pivotal platform for disseminating high-quality research and innovative findings since its inception in 2003. Published by the Association of Basic Medical Science Federation of Bosnia and Herzegovina, this open-access journal makes substantial contributions to the medical sciences, fostering collaboration and knowledge sharing among researchers, healthcare professionals, and students alike. With a distinguished Q2 ranking in Medicine (Miscellaneous) for 2023 and a remarkable 91st percentile Scopus rank in General Medicine, the journal emphasizes its commitment to excellence and relevance in contemporary medical research. It operates out of Sarajevo, Bosnia and Herzegovina, continuing to attract diverse contributions from a global audience and solidifying its role in advancing basic medical science. The journal's broad scope, covering innovative and diverse medical topics, promotes interdisciplinary approaches that are essential in addressing today's health challenges.

The European Journal of Inflammation, published by SAGE Publications Inc, is a dedicated platform for the dissemination of innovative research in the field of immunology and inflammation, with a strong commitment to advancing scientific knowledge in allergy and related disciplines. Established in 2004, this open access journal has been providing a crucial avenue for researchers, practitioners, and students to share findings and insights in an increasingly important area of health science, especially since transitioning to open access in 2017. With an ISSN of 1721-727X and an E-ISSN of 2058-7392, the journal has made significant strides, though currently holds a Q4 category ranking in the realms of Immunology and Allergy according to 2023 quartiles. The journal's visibility is further reflected in its Scopus ranks, positioned at #190 in Medicine (Immunology and Allergy) and #206 in Immunology and Microbiology (Immunology). Its scope encompasses a wide range of topics related to inflammation, making it a valuable resource for those engaged in cutting-edge research. With a rapidly evolving landscape in immunological research, the European Journal of Inflammation stands as an essential resource for anyone looking to stay informed and contribute to this vital area of medicine.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.